Cargando…

Therapeutic drug monitoring in a developing nation: a clinical guide

Therapeutic drug monitoring is aimed at using drug concentration measurements to manage a patient’s medication requirement and optimise clinical outcome, particularly in respect of drugs with narrow therapeutic index. Typically, immunoassay methods of various techniques are employed with the advanta...

Descripción completa

Detalles Bibliográficos
Autor principal: Nwobodo, Ndubuisi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100237/
https://www.ncbi.nlm.nih.gov/pubmed/25289142
http://dx.doi.org/10.1177/2054270414531121
_version_ 1782326640489005056
author Nwobodo, Ndubuisi
author_facet Nwobodo, Ndubuisi
author_sort Nwobodo, Ndubuisi
collection PubMed
description Therapeutic drug monitoring is aimed at using drug concentration measurements to manage a patient’s medication requirement and optimise clinical outcome, particularly in respect of drugs with narrow therapeutic index. Typically, immunoassay methods of various techniques are employed with the advantage of rapid turnaround time and ease of operation. The chromatographic methods are specific and cost effective, though more demanding and require technical expertise. The most crucial aspect of any therapeutic drug monitoring service is the expert clinical interpretation of drug concentration measurements taking into consideration individual pharmacokinetic variability in drug disposition across different populations. The setting up of a therapeutic drug monitoring service requires enormous resources, both in terms of equipment and trained personnel. This poses considerable constraints in developing countries due to limited scarce resources, coupled with ignorance among health practitioners on the relevance of therapeutic drug monitoring in clinical practice. Consequently, the need for advocacy, training and encouragement of health practitioners on the usefulness of therapeutic drug monitoring in enhancing patient care and overall clinical outcome in a developing country such as Nigeria can never be over-emphasised.
format Online
Article
Text
id pubmed-4100237
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-41002372014-10-06 Therapeutic drug monitoring in a developing nation: a clinical guide Nwobodo, Ndubuisi JRSM Open Clinical Review Therapeutic drug monitoring is aimed at using drug concentration measurements to manage a patient’s medication requirement and optimise clinical outcome, particularly in respect of drugs with narrow therapeutic index. Typically, immunoassay methods of various techniques are employed with the advantage of rapid turnaround time and ease of operation. The chromatographic methods are specific and cost effective, though more demanding and require technical expertise. The most crucial aspect of any therapeutic drug monitoring service is the expert clinical interpretation of drug concentration measurements taking into consideration individual pharmacokinetic variability in drug disposition across different populations. The setting up of a therapeutic drug monitoring service requires enormous resources, both in terms of equipment and trained personnel. This poses considerable constraints in developing countries due to limited scarce resources, coupled with ignorance among health practitioners on the relevance of therapeutic drug monitoring in clinical practice. Consequently, the need for advocacy, training and encouragement of health practitioners on the usefulness of therapeutic drug monitoring in enhancing patient care and overall clinical outcome in a developing country such as Nigeria can never be over-emphasised. SAGE Publications 2014-07-08 /pmc/articles/PMC4100237/ /pubmed/25289142 http://dx.doi.org/10.1177/2054270414531121 Text en © The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(http://www.uk.sagepub.com/aboutus/openaccess.htm).
spellingShingle Clinical Review
Nwobodo, Ndubuisi
Therapeutic drug monitoring in a developing nation: a clinical guide
title Therapeutic drug monitoring in a developing nation: a clinical guide
title_full Therapeutic drug monitoring in a developing nation: a clinical guide
title_fullStr Therapeutic drug monitoring in a developing nation: a clinical guide
title_full_unstemmed Therapeutic drug monitoring in a developing nation: a clinical guide
title_short Therapeutic drug monitoring in a developing nation: a clinical guide
title_sort therapeutic drug monitoring in a developing nation: a clinical guide
topic Clinical Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100237/
https://www.ncbi.nlm.nih.gov/pubmed/25289142
http://dx.doi.org/10.1177/2054270414531121
work_keys_str_mv AT nwobodondubuisi therapeuticdrugmonitoringinadevelopingnationaclinicalguide